Details

NameSymbolSector
VISTA PHARMACEUTICALS LTD.VISTAPHPharmaceuticals
Open
6.08
High
6.34
Low
5.91
Close
6.27
Volume
2726
Exchange
bse
Time
16-Oct-2026

Outlook

Score:  

2

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Vista Pharmaceuticals is  
None
Estimated Stoploss of Vista Pharmaceuticals is ₹  
5.91
Vista Pharmaceuticals has a  
Bullishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Vista Pharmaceuticals is  
Unpredictableℹ
. 

Trend

Vista Pharmaceuticals is in  
Sideways trendℹ
. 
Price of Vista Pharmaceuticals is  
Downℹ
 by  

1.42

%. 
Target
Buy @ 

5.51

Sell @ 

7.67

Current @ 

6.27

Volume

The trade volumes of Vista Pharmaceuticals have become  
Deficientℹ
The volume trend for Vista Pharmaceuticals is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Vista Pharmaceuticals is  

Down

 by  

75.12

% 

Valuation

The current market price of Vista Pharmaceuticals is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 60cr and total assets worth ₹ 60cr, the balance sheet of Vista Pharmaceuticals is:  
Balancedℹ
. 
Cashflow
Vista Pharmaceuticals has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2025)

42.86% i.e. ₹ 6cr spent in operatingℹ
0% in investingℹ
57.14% i.e. ₹ 8cr earned in financingℹ
0% in otherℹ
Vista Pharmaceuticals has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2024)

44.44% i.e. ₹ 4cr spent in operatingℹ
0% in investingℹ
55.56% i.e. ₹ 5cr earned in financingℹ
0% in otherℹ
Income
The income of Vista Pharmaceuticals is  

₹ 1cr

 and  

Loss

 is :  

₹ 2cr

(*Sep 2025)

Vista Pharmaceuticals Losses increased by:  

100

% and Income is Up by:  

0

% 

(*Sep 2025)

The income of Vista Pharmaceuticals is  

₹ 1cr

 and  

Loss

 is :  

₹ 1cr

(*Jun 2025)

Vista Pharmaceuticals Losses increased by:  

0

% and Income is Down by:  

66.67

% 

(*Jun 2025)

The income of Vista Pharmaceuticals is  

₹ 3cr

 and  

Loss

 is :  

₹ 1cr

(*Mar 2025)

Vista Pharmaceuticals Losses increased by:  

0

% and Income is Up by:  

50

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.